Literature DB >> 6661374

Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.

R Jochemsen, J G Wesselman, J Hermans, C J van Boxtel, D D Breimer.   

Abstract

Pharmacokinetics and bioavailability of brotizolam after i.v. and oral administration were studied in healthy young volunteers. Kinetic parameters after i.v. administration were: volume of distribution 0.66 +/- 0.19 1/kg, total plasma clearance 113 +/- 28 ml/min, distribution half-life 11 +/- 6 min, and elimination half-life 4.8 +/- 1.4 h (mean values +/- s.d.). Kinetic parameters after oral administration were: absorption lag-time 8 +/- 12 min, absorption half-life 10 +/- 11 min, and elimination half-life 5.1 +/- 1.2 h (mean values +/- s.d.). Bioavailability of brotizolam was 70 +/- 22% when calculated by comparing oral and intravenous area-under-curve values, corrected for intra-individual half-life differences. An alternative calculation method, which is relatively independent of large clearance variations, provided a bioavailability of 70 +/- 24% (range: 47-117%).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661374      PMCID: PMC1428208          DOI: 10.1111/j.1365-2125.1983.tb02302.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.

Authors:  D J Greenblatt; R I Shader; K Franke; D S MacLaughlin; J S Harmatz; M D Allen; A Werner; E Woo
Journal:  J Pharm Sci       Date:  1979-01       Impact factor: 3.534

2.  Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses.

Authors:  B Saletu; J Grünberger; J Volavka; P Berner
Journal:  Arzneimittelforschung       Date:  1979

3.  Automated gas chromatography for studies of midazolam pharmacokinetics.

Authors:  D J Greenblatt; A Locniskar; H R Ochs; P M Lauven
Journal:  Anesthesiology       Date:  1981-08       Impact factor: 7.892

4.  Assay of triazolam in plasma by capillary gas chromatography.

Authors:  R Jochemsen; D D Breimer
Journal:  J Chromatogr       Date:  1981-05-08

5.  Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.

Authors:  D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

Review 7.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

8.  Diazepam disposition determinants.

Authors:  D J Greenblatt; M D Allen; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

9.  Disposition of intravenous diazepam in young men and women.

Authors:  H G Giles; E M Sellers; C A Naranjo; R C Frecker; D J Greenblatt
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Studies on sleep and performance with a triazolo-1, 4-thienodiazepine (brotizolam).

Authors:  A N Nicholson; B M Stone; P A Pascoe
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

View more
  16 in total

1.  Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.

Authors:  R Jochemsen; J G Wesselman; C J van Boxtel; J Hermans; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 2.  Hypnotics. Their place in therapeutics.

Authors:  A N Nicholson
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

3.  Pharmacokinetics of oral brotizolam in patients with liver cirrhosis.

Authors:  R Jochemsen; R P Joeres; J G Wesselman; E Richter; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Pharmacokinetics of brotizolam in the elderly.

Authors:  R Jochemsen; K L Nandi; D Corless; J G Wesselman; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Tolerance studies with brotizolam in hospitalized patients.

Authors:  O von Delbrück; E Goetzke; C Nagel
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Single and multiple dose pharmacokinetics of etizolam in healthy subjects.

Authors:  C Fracasso; S Confalonieri; S Garattini; S Caccia
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Comparative studies on the efficacy of brotizolam and nitrazepam: a multi-centre study.

Authors:  H Lohmann; O von Delbrück; P Findeisen
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Brotizolam as a pre-operative hypnotic.

Authors:  F Ahmad; P Rittmeyer; E Goetzke; J Köster
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

9.  Efficacy and tolerance: comparative studies with brotizolam and flunitrazepam.

Authors:  E Goetzke; P Findeisen; I B Welbers
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  Elimination of brotizolam in elderly patients after multiple doses.

Authors:  W D Bechtel; E Goetzke
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.